Psychosocial profile of the patients with inflammatory bowel disease

Ilias,Tiberia; Bungau,Simona; Tit,Delia   Mirela; Maghiar,Daniela; Hocopan,Cristian; Brata,Roxana; Bratu,Ovidiu   Gabriel; Negrut,Nicoleta; Diaconu,Camelia; Fratila,Ovidiu

doi:10.3892/etm.2020.8816

Psychosocial profile of the patients with inflammatory bowel disease

Authors:
- Tiberia Ilias
- Simona Bungau
- Delia Mirela Tit
- Daniela Maghiar
- Cristian Hocopan
- Roxana Brata
- Ovidiu Gabriel Bratu
- Nicoleta Negrut
- Camelia Diaconu
- Ovidiu Fratila
View Affiliations

Affiliations: Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania, Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania, Emergency Clinical County Hospital, 410169 Oradea, Romania, Clinical Department 3, ‘Carol Davila’ University of Medicine and Pharmacy, 050474 Bucharest, Romania, Department of Psycho-Neuroscience and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania, Department 5, ‘Carol Davila’ University of Medicine and Pharmacy, 050474 Bucharest, Romania
Published online on: May 29, 2020 https://doi.org/10.3892/etm.2020.8816
Pages: 2493-2500

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Inflammatory bowel disease (IBD) is a chronic, disabling entity of unknown aetiology, with negative impact on the patient's life, including psychological patterns. This study assessed multiple psychosocial factors (satisfaction with life, coping mechanisms, emotional profile, mental recognition of the disease and cognition schemes related to patients' demographic characteristics, clinical picture, form and duration of the disease, therapeutic plans) in IBD patients vs. a healthy group. This non‑interventional study comprised 60 participants who attended for medical advice/check‑up as an ambulatory visit or during hospitalization. The patients completed questionnaires after receiving explanations from the psychologist. Statistical analyses (Kolmogorov‑Smirnov test, Independent‑Samples t-test, One‑Way ANOVA and Post Hoc Multiple Comparisons) were conducted using IMB for the Social Sciences (SPSS), version 20 (P≤0.05). IBD patients (G1) are more hostile when compared to the healthy group (G2). Those who experience abdominal pain are more likely to use active coping mechanisms and those who experience fatigue are more likely to use acceptance, emotional venting, behavioural disengagement and mental disengagement. G1 have higher levels of others‑downing vs. G2. Regarding negative emotions, IBD patients generally experience more negative emotions compared to healthy participants (who have higher levels of life satisfaction). Regarding the perception of illness, there are no differences between patients in terms of illness coherence, personal or treatment control, consequences, timeline, or emotional representations. Results indicate that psychological factors and different characteristics of IBD patients play a relevant role in the way these patients deal with their disease.

View Figures

View References

1	Burisch J, Jess T, Martinato M and Lakatos PL: The burden of inflammatory bowel disease in Europe. J Crohn's Colitis. 7:322–337. 2013.PubMed/NCBI View Article : Google Scholar
2	Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JC, Chan FK, et al: Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 390:2769–2778. 2018.PubMed/NCBI View Article : Google Scholar
3	Gheorghe C, Pascu O, Gheorghe L, Iacob R, Dumitru E, Tantau M, Vadan R, Goldis A, Balan G, Iacob S, et al: Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: A multicentre study. Eur J Gastroenterol Hepatol. 16:1153–1159. 2004.PubMed/NCBI View Article : Google Scholar
4	Mocanu D, Catuneanu AM, Diculescu M, Gologan S and Sporea I: Current epidemiologic trends in Crohn's disease: Data from a tertiary refferal centre in Bucharest. Maedica (Buchar). 5:95–101. 2010.PubMed/NCBI
5	Szigethy EM, Allen JI, Reiss M, Cohen W, Perera LP, Brillstein L, Cross RK, Schwartz DA, Kosinski LR, Colton JB, et al: The impact of mental and psychosocial factors on the care of patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 15:986–997. 2017.PubMed/NCBI View Article : Google Scholar
6	Buss AH and Perry M: The aggression questionnaire. J Pers Soc Psychol. 63:452–459. 1992.PubMed/NCBI View Article : Google Scholar
7	Carver CS, Scheier MF and Weintraub JK: Assessing coping strategies: A theoretically based approach. J Pers Soc Psychol. 56:267–283. 1989.PubMed/NCBI View Article : Google Scholar
8	Chamberlain JM and Haaga DAF: Unconditional self-acceptance and psychological health. J Ration Emot Cogn Behav Ther. 19:163–176. 2001.
9	Flett G, Besser A, Davis RA and Hewit P: Dimensions of perfectionism, unconditional self-acceptance, and depression. J Ration Emot Cogn Behav Ther. 21:119–138. 2003.
10	Shepard L: Self-acceptance: The evaluative component of the self-concept construct. Am Ed Res J. 16:139–160. 1979.
11	Lindner H, Kirkby R, Wertheim F and Birch P: A brief assessment of irrational thinking: The Shortened General Attitude and Belief Scale. Cognit Ther Res. 23:651–663. 1999.
12	Ellis A and Bernard ME (eds): What is rational-emotive therapy? In: Clinical Applications of Rational-Emotive Therapy. PlenumPress, New York, NY, pp1-26, 1985.
13	Opris D and Macavei M: Profile of emotional distress. In: Clinical Evaluation System. David D (ed). RTS Publishing, Cluj-Napoca, 2007.
14	Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD and Buick D: The revised illness perception questionnaire (IPQ-R). Psychol Health. 17:1–16. 2002.
15	Weinman J, Petrie K, Sharpe N and Walker S: Causal attributions in patients and spouses following a heart attack and subsequent lifestyle changes. Br J Health Psychol. 5:263–273. 2000.
16	Abdel-Daim MM, El-Tawil OS, Bungau SG and Atanasaov AG: Applications of antioxidants in metabolic disorders and degenerative diseases: Mechanistic approach. Oxid Med Cell Longev. 2019(4179676)2019.PubMed/NCBI View Article : Google Scholar
17	Pallag A, Roşca E, ţiŢ DM, MuŢiu G, Bungău SG and Pop OL: Monitoring the effects of treatment in colon cancer cells using immunohistochemical and histoenzymatic techniques. Rom J Morphol Embryol. 56:1103–1109. 2015.PubMed/NCBI
18	Ben Thabet J, Charfi N, Mnif L, Yaich S, Zouari L, Zouari N, Tahri N, Damak J and Maalej M: Emotional disorders and inflammatory bowel disease. Tunis Med. 90:557–563. 2012.PubMed/NCBI(In French).
19	Byrne G, Rosenfeld G, Leung Y, Qian H, Raudzus J, Nunez C and Bressler B: Prevalence of anxiety and depression in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol. 2017(6496727)2017.PubMed/NCBI View Article : Google Scholar
20	Boye B, Lundin KE, Leganger S, Mokleby K, Jantschek G, Jantschek I, Kunzendorf S, Benninghoven D, Sharpe M, Wilhelmsen I, et al: The INSPIRE study: Do personality traits predict general quality of life (short form-36) in distressed patients with ulcerative colitis and Crohn's disease? Scand J Gastroenterol. 43:1505–1513. 2008.PubMed/NCBI View Article : Google Scholar
21	La Barbera D, Bonanno B, Rumeo MV, Alabastro V, Frenda M, Massihnia E, Morgante MC, Sideli L, Craxì A, Cappello M, et al: Alexithymia and personality traits of patients with inflammatory bowel disease. Sci Rep. 7(41786)2017.PubMed/NCBI View Article : Google Scholar
22	Casati J, Toner BB, de Rooy EC, Drossman DA and Maunder RG: Concerns of patients with inflammatory bowel disease: A review of emerging themes. Dig Dis Sci. 45:26–31. 2000.PubMed/NCBI View Article : Google Scholar
23	Faust AH, Halpern LF, Danoff-Burg S and Cross RK: Psychosocial factors contributing to inflammatory bowel disease activity and health-related quality of life. Gastroenterol Hepatol (NY). 8:173–181. 2012.PubMed/NCBI
24	Habibi F, Habibi ME, Gharavinia A, Mahdavi SB, Akbarpour MJ, Baghaei A and Emami MH: Quality of life in inflammatory bowel disease patients: A cross-sectional study. J Res Med Sci. 22(104)2017.PubMed/NCBI View Article : Google Scholar
25	Taft TH, Keefer L, Leonhard C and Nealon-Woods M: Impact of perceived stigma on inflammatory bowel disease patient outcomes. Inflamm Bowel Dis. 15:1224–1232. 2009.PubMed/NCBI View Article : Google Scholar
26	Sammut J, Scerri J and Xuereb RB: The lived experience of adults with ulcerative colitis. J Clin Nurs. 24:2659–2667. 2015.PubMed/NCBI View Article : Google Scholar
27	Woodward S, Dibley L, Coombes S, Bellamy A, Clark C, Czuber-Dochan W, Everelm L, Kutner S, Sturt J and Norton C: Identifying disease-specific distress in patients with inflammatory bowel disease. Br J Nurs. 25:649–660. 2016.PubMed/NCBI View Article : Google Scholar
28	Vegni E, Gilardi D, Bonovas S, Corrò BE, Menichetti J, Leone D, Mariangela A, Furfaro F, Danese S and Fiorino G: Illness perception in inflammatory bowel disease patients is different between patients with active disease or in remission: A prospective cohort study. J Crohn's Colitis. 13:417–423. 2019.PubMed/NCBI View Article : Google Scholar
29	Draghici T, Negreanu L, Bratu OG, Stoian AP, Socea B, Neagu TP, Stanescu AM, Manuc D and Diaconu CC: Paraneoplastic syndromes in digestive tumors: A review. Rom Biotechnol Lett. 24:813–819. 2019.
30	Manea M, Marcu D, Motofei I, Socea B, Stoian AP, Bratu OG, Gaman MA, Gaman AM, Stanescu AM and Diaconu C: Cardiovascular risk in patients with inflammatory bowel diseases: A review. Rom Biotechnol Lett. 24:366–373. 2019.